drugset / Trial / NCT05213156

Concentration of Ofloxacin Into the Aqueous Humour of Patients With Dry Eye Disease

NCT05213156

RandomizedFactorialQuadruple-blindScreening

Summary

After topical installation of one drop of 0.3% commercially available ofloxacin (Oxatrex®) four times at intervals of 15min in catarract patients with Dry Eye Disease, aqueous humour samples will be collected intraoperatively, one hour after the last installation. Concentration of ofloxacin in aqueous humour will be measured by HPLC-MS/MS.

Timeline

Start
2019-09-24
Primary completion
2022-01-24
Completion
2022-01-24

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ofloxacin Small molecule 0.3 % Topical

Indications